Clinical trial
Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC
NCT04541251
Study timeline
Study start (actual)2020-08-01Date precision: day
Registry last updated2021-06-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancer, Non-small Cellunresolved
Artificial Intelligenceunresolved
Interventions
Sponsors & collaborators
Guangdong Provincial People's Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04541251 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.